SFEBES2022 Poster Presentations Metabolism, Obesity and Diabetes (96 abstracts)
Remote Blood Glucose Level monitoring amongst women with Gestational Diabetes Mellitus during COVID-19
Benái Paponette , Maria Tighe , Lisa Kelly , Majella Toomey , Ann Ferguson , Patricia Bruen , Karen O Toole , Deirdre Doherty , Patricia Murray , Kelley Hennigan , Catherine McHugh & Siobhan Bacon
Sligo University Hospital, Sligo, Ireland
Introduction: Gestational diabetes mellitus (GDM) is any degree of glucose intolerance developed during pregnancy1. Remote Blood Glucose Monitoring (BGM) may facilitate more effective communication between women with GDM and physicians.
Objectives: To evaluate the effectiveness of remote BGM (using OneTouch Verio system) in the management of women with GDM during COVID-19 and assess the impact on delivery modality. Diabetes in pregnancy NICE guidelines were applied.
Methodology: This retrospective study was performed on 217 women with GDM attending Sligo University Hospital (95 in 2019 and 122 in 2021). Data on HbA1c, treatment modality and OneTouch Verio usage were collected using the diabetes Prowellness database. Data on delivery modality were collected using the Euroking database.
Results: In 2019, (pre-pandemic and remote BGM unavailable), majority of women with GDM were diet controlled (39%). 33% required metformin, 11% on insulin and 17% on metformin and insulin. In 2021, majority (43%) were diet controlled, 28% on metformin, 17% on insulin and 12% on both. In 2021(during pandemic), we compared treatment modality amongst women with GDM using remote BGM (58%) vs those not using same. In the remote BGM subgroup, 38% were diet controlled, 30% on metformin, 12% on insulin and 20% on both. The mode of delivery in 47% of these women was caesarean section (34% elective and 13% emergency). In the subgroup of women not using remote BGM in 2021; 49% diet controlled, 25% on metformin, 24% on insulin and 2% on both. The mode of delivery in 28% of these women was caesarean section (6% elective and 22% emergency).
Conclusion: During the COVID-19 pandemic, the use of remote BGM resulted in more women being treated with insulin. Of note, there were less emergency caesarean sections amongst women using remote BGM.
Reference: 1. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care. 2003; 26(1): s103-s105.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more